FDA Adverse Event Other Summary report: N

LENSAR LASER SYSTEM -FS 3D

MDR report key: 3772357 · Received March 6, 2014

Report

Report Number
3009026057-2014-00002
Event Type
Other
Date Received
March 6, 2014
Date of Event
February 17, 2014
Report Date
March 6, 2014
Manufacturer
LENSAR INC
Product Code
OOE
PMA / PMN Number
K120214
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MI, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

ANALYSIS OF PATIENT SURGERY FILES REVEALS AN ASYMMETRIC DOCK AS EVIDENCED BY A DECENTERED SUCTION RING ON DOWN THE PIPE IMAGE CAPTURES. SIGNIFICANT EYE MOVEMENT IS NOTED PERIODICALLY BEFORE AND DURING COMPLETION OF THE ANTERIOR CAPSULOTOMY AND THROUGHOUT THE REST OF THE PROCEDURE. THIS MOVEMENT IS LIKEWISE EVIDENCED THROUGH THE DISPLACEMENT OF CAPSULOTOMY CYLINDERS ON SEQUENTIAL IMAGE FRAMES. BUBBLE BREAKTHROUGH IS EXTREMELY ASYMMETRIC AND BUBBLE DENSITY IS GREATER IN THE SUPERIOR QUADRANT OF THE FRAME (NASALLY) COMPARED TO THE INFERIOR QUADRANT (TEMPORALLY). THESE MULTIPLE CAPSULOTOMY RINGS APPLIED UNDER THE ANTERIOR CAPSULE LIKELY WEAKENED THE RADIAL STRENGTH OF THE CAPSULAR RIM, WHICH WAS FURTHER COMPOUNDED BY THE PATIENT MOVEMENT DURING THE BREAKTHROUGH OF THE ANTERIOR CAPSULOTOMY ITSELF. AN ANTERIOR RADIAL TEAR COULD POTENTIALLY OCCUR IN THIS SCENARIO AS A RESULT OF INHERENT RADIAL FORCES EXERTED UPON THE ANTERIOR CAPSULAR RIM BY THE SURROUNDING OCULAR APPARATUS.

Description of Event or Problem · 1

DOCTOR REPORTED TO A LENSAR CLINICAL APPLICATION SPECIALIST (CAS) ON (B)(6) 2014 THAT HE COMPLETED LASER TREATMENT 100% ON A PATIENT. DURING CAPSULOTOMY BUTTON REMOVAL UNDER MICROSCOPE, HE NOTICED A RADIAL TEAR. HE STATED THAT HE PROCEEDED ON WITH CAUTION AND THE REMAINDER OF SURGERY WENT WELL. NO VITRECTOMY WAS PERFORMED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
136882 LENSAR LASER SYSTEM -FS 3D LENSAR LASER SYSTEM -FS 3D OOE LENSAR INC NA NA

Patients

Seq Age Sex Outcome Treatment
1 UNK Other